General Information
-
DRAMP ID
- DRAMP29009
-
Peptide Name
- A4K14-citropin1.1-Sp3
-
Sequence
- GLFAVⓍKKVⓍSVIKGL
-
Sequence Length
- 16
-
Original Sequence
- GLFAVIKKVASVIKGL
-
Source
- Synthetic construct
Activity Information
-
Biological Activity
- Antimicrobial, Anticancer
-
Comments
- Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.
-
Target Organism
-
- [Ref.33363118] Cancer cell lines: C4-2B (IC50 = 17.89 μM), A549 (IC50 = 12.11 μM), U87 (IC50 = 11.93 μM), MCF-7 (11.92 μM)
-
Hemolytic Activity
-
- No hemolytic activity information found.
-
Cytotoxicity
- No cytotoxicity information found in the reference(s) presented
Structure Information
-
Linear/Cyclic
- Cyclic (Stapled)
-
N-terminal Modification
- Acetylation
-
C-terminal Modification
- Amidation
-
Special Amino Acid and Stapling Position
- ① The Ⓧ (position: 6 and 10) in sequence indicate (S)-2-(4-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.
-
Stereochemistry
- L
-
Secondary Structure
- Helicity = 49.2% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)
-
Structure Description
- [Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.
-
Helical Wheel Diagram
-
Predicted Structure
- There is no predicted structure for DRAMP29009.
Physicochemical Information
-
Formula
- C₈₆H₁₄₈N₂₀O₁₈
Absent Amino Acids
- CDEHMNPQRTWY
Common Amino Acids
- KV
Mass
- 1749.13
PI
- /
-
Basic Residues
- 3
Acidic Residues
- 0
Hydrophobic Residues
- 8
Hydrophobicity
- /
Polar Residues
- 3
DRAMP29009
Literature Information
- Literature 1
-
Title
- Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides
-
Pubmed ID
- 33363118
-
Reference
- Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.
-
Author
- Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu